Citi Group has upgraded BioAge Labs to 'Buy' and doubled its price target, citing strong prospects for its obesity drug pipeline and upcoming data releases.
#YonhapInfomax #BioAgeLabs #CitiGroup #ObesityDrug #BGE102 #PriceTarget #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=86911